2022 annual financial data
Neuphoria Therapeutics 2022 Financial results
Neuphoria Therapeutics 2022 financial results with verified reported values.
Direct answer
Revenue was 383,156 USD.
Operating income was -31,017,208 USD and net income was -22,939,197 USD.
Operating cash flow was -21,753,190 USD.
Get free Neuphoria Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 383,156 USD
- Operating income
- -31,017,208 USD
- Net income
- -22,939,197 USD
- Operating cash flow
- -21,753,190 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Neuphoria Therapeutics financial years